These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18208369)

  • 1. Mammalian target of rapamycin as a therapeutic target in oncology.
    Abraham RT; Eng CH
    Expert Opin Ther Targets; 2008 Feb; 12(2):209-22. PubMed ID: 18208369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.
    Rao RD; Buckner JC; Sarkaria JN
    Curr Cancer Drug Targets; 2004 Dec; 4(8):621-35. PubMed ID: 15578919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR and cancer: insights into a complex relationship.
    Sabatini DM
    Nat Rev Cancer; 2006 Sep; 6(9):729-34. PubMed ID: 16915295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mTOR for cancer treatment.
    Rubio-Viqueira B; Hidalgo M
    Adv Exp Med Biol; 2006; 587():309-27. PubMed ID: 17163174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
    Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
    Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR pathway and mTOR inhibitors as agents for cancer therapy.
    Baldo P; Cecco S; Giacomin E; Lazzarini R; Ros B; Marastoni S
    Curr Cancer Drug Targets; 2008 Dec; 8(8):647-65. PubMed ID: 19075588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the role of mTOR in cancer.
    Guertin DA; Sabatini DM
    Cancer Cell; 2007 Jul; 12(1):9-22. PubMed ID: 17613433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR signalling in human cancer.
    Albanell J; Dalmases A; Rovira A; Rojo F
    Clin Transl Oncol; 2007 Aug; 9(8):484-93. PubMed ID: 17720651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting mTOR inhibitors as anticancer agents.
    Teng QX; Ashar YV; Gupta P; Gadee E; Fan YF; Reznik SE; Wurpel JND; Chen ZS
    Drug Discov Today; 2019 Oct; 24(10):2086-2095. PubMed ID: 31173912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the mTOR pathway using deforolimus in cancer therapy.
    Mahalingam D; Sankhala K; Mita A; Giles FJ; Mita MM
    Future Oncol; 2009 Apr; 5(3):291-303. PubMed ID: 19374536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing mTOR-targeted cancer therapy.
    Wang X; Sun SY
    Expert Opin Ther Targets; 2009 Oct; 13(10):1193-203. PubMed ID: 19694499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [mTOR inhibitor].
    Muro K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/Akt/mTOR pathway as a target for cancer therapy.
    Morgensztern D; McLeod HL
    Anticancer Drugs; 2005 Sep; 16(8):797-803. PubMed ID: 16096426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and challenges associated with targeting mTOR for cancer therapy.
    Dowling RJ; Pollak M; Sonenberg N
    BioDrugs; 2009; 23(2):77-91. PubMed ID: 19489650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mTOR for cancer treatment.
    Rubio-Viqueira B; Hidalgo M
    Curr Opin Investig Drugs; 2006 Jun; 7(6):501-12. PubMed ID: 16784020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibitors in cancer therapy.
    Zaytseva YY; Valentino JD; Gulhati P; Evers BM
    Cancer Lett; 2012 Jun; 319(1):1-7. PubMed ID: 22261336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of mammalian target of rapamycin inhibitors in lung cancer.
    Gómez-Martín C; Rubio-Viqueira B; Hidalgo M
    Clin Lung Cancer; 2005 Sep; 7 Suppl 1():S13-8. PubMed ID: 16159415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway.
    Smolewski P
    Anticancer Drugs; 2006 Jun; 17(5):487-94. PubMed ID: 16702804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibitors in the treatment of cancer.
    Fasolo A; Sessa C
    Expert Opin Investig Drugs; 2008 Nov; 17(11):1717-34. PubMed ID: 18922108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.